CD5 and B-cell chronic lymphocytic leukemia: Recent compelling evidence suggests that CD5 abnormal expression is involved in the development and progression of B-CLL through negative regulation of BCR-induced signaling or signaling pathways triggered by CD5 itself [7–9].